PLAY PODCASTS
Josh Bartch, Mydecine Innovations Group
Episode 14

Josh Bartch, Mydecine Innovations Group

Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch. David and Josh take some time to talk about Mydecine as a company, and, what path they're taking in 2021, the passing of Measure 109 in Oregon, aiding veterans through psychedelics, and more.

Psychedelic Spotlight Podcast · Mydecine Innovations Group, Psychedelic Spotlight, Global Trac Solutions Inc., PSYC, David Flores, Josh Bartch

January 27, 202117m 7s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

To learn more about Mydecine Innovations Group and the work they're doing be sure to visit their website, Mydecine.com. Investors can find them on the Canadian Securities Exchange under the symbol MYCO, or on the OTC Markets under the symbol MYCOF.

Get the latest industry news around all things psychedelics by visiting our website, PsychedelicSpotlight.com, and be sure to subscribe to our newsletter to never miss a thing.

Topics

david floresmydecine innovations grouppsyc newspsychedelic spotlightjosh bartchglobal trac solutions inc.psycpsychedelics